Jim Cramer provides his opinion on various stocks at lightning speed, including Sarepta Therapeutics.
Sundial Growers Inc. (NASDAQ: SNDL) ("Sundial" or the "Company") reported its financial and operational results for the first quarter ended March 31, 2022. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated.
Shares of the e-commerce platform company Shopify (NYSE: SHOP) were sliding today, on seemingly no company-specific news. Instead, investors were likely continuing to fear that high inflation and interest rate hikes by the Federal Reserve could slow down the economy. Investors have grown increasingly concerned that the Fed won't be able to pull off a so-called soft landing for the economy as it raises the federal funds rate to tamp down inflation, which is running at a nearly 40-year high.
Editor-in-chief MJ Day explains why Kim K. was a fit for the cover.
Elon Musk just waved a giant middle finger at Twitter's embattled CEO.
“Why did they delay their response? I think in retrospect, yes, it was a mistake."
Deliveries of the Dreamliner have been almost completely idled since late 2020, as the company works through production issues.
Biotech stocks have taken a beating to start the year, with the S&P Biotech Industry Index down more than 49% so far. There are several reasons a biotech stock could go parabolic -- that is, have its shares see a sharp rise in a short period. The company could be the buyout target of a merger deal with a larger pharmaceutical company.
"The obvious precedent is FDIC insurance (up to $250,000 per person)," Vitalik Buterin tweeted, adding that he “strongly supports” helping the “average UST smallholder."
The Dow Jones index finished last week with a modest loss, even after a late-week rally in Friday’s session. It marked the seventh week in a row that the Dow posted a weekly loss, it’s longest such streak in two decades. That capped a brutal season of market losses, all across the board. The S&P 500 is down 16% this year, and the NASDAQ, with a year-to-date loss of 25%, is into bear market territory. Investors have been giving conflicting sets of reactions to the market’s fall. Coming at it from
The Redmond-based software maker is increasing performance pay and annual stock award ranges, CEO Satya Nadella said in a memo to employees. The move comes as Microsoft faces intense competition for talent, including from rival Amazon.
The rout in the financial markets raises questions about the ability of upstart companies to raise funds.
Yahoo Finance’s Ines Ferre joins the Live show to break down the latest stock moves.
Consumers (and investors) frustrated by a lack of electric vehicle (EV) chargers will be hoping companies like Charge Enterprises can keep its growth going. The newly-public EV charging infrastructure company reported first quarter revenue of $163.0 million, a jump of nearly 47% from a year ago.
In this article, we discuss 10 dividend stocks to buy for financial freedom. If you want to see more stocks in this selection, click 5 Dividend Stocks to Buy for Financial Freedom. According to Goldman Sachs, investors expect higher share repurchases and increasing dividends in 2022. The investment bank raised the buyback estimate to $1 […]
Many high-growth tech stocks crashed over the past six months as rising interest rates drove investors toward more conservative investments. In anticipation of that stabilization, let's take a closer look at three high-growth tech stocks -- Airbnb (NASDAQ: ABNB), Adyen (OTC: ADYE.Y), and Palo Alto Networks (NASDAQ: PANW) -- that deserve to be bought without any hesitation, even in this challenging market. Airbnb struggled during the pandemic, but its growth is accelerating as people start to travel again in a post-lockdown world.
(Bloomberg) -- A selloff in cryptocurrencies resumed Monday, with Bitcoin dropping back below $30,000 with global equity markets remaining under pressure. Most Read from BloombergMeet the Hedge-Fund Manager Who Warned of Terra’s $60 Billion ImplosionU.S. Stocks Extend Losses in Late Session Selloff: Markets WrapGoldman’s Blankfein Says US at 'Very, Very High Risk' of RecessionOmicron Is Turning Out to Be a Weak VaccineHow Omicron Infection Turbo-Charges Vaccinated People’s ImmunityThe largest cr
All stocks have bad days at least once in a while, but Monday for Tonix Pharmaceuticals (NASDAQ: TNXP) was one of the ugliest trading sessions in its history. The company's stock lost nearly one-third of its value after the company announced a financial engineering move that sent investors scrambling for the exits. Tonix announced Monday afternoon that it is effecting a 1-for-32 reverse split of its common stock.
Former president is obligated to first post to Truth Social.
The Food and Drug Administration approved an Eli Lilly diabetes drug it described as "novel," prodding LLY stock closer to a breakout.
A Wall Street whale disclosed he has opened a position in the Chinese electric vehicle maker, and an analyst chimed in with a buy rating.